Armistice Capital’s Avalo Therapeutics AVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $7.73M | Buy |
|
|||||
|
2022
Q4 | $20M | Hold |
|
|||||
|
2022
Q3 | $13.2M | Hold |
|
|||||
|
2022
Q2 | $23.8K | Hold |
|
|||||
|
2022
Q1 | $34.5M | Buy |
|
|||||
|
2021
Q4 | $76.5M | Hold |
|
|||||
|
2021
Q3 | $98.1M | Buy |
|
|||||
|
2021
Q2 | $128M | Buy |
|
|||||
|
2021
Q1 | $98.6M | Buy |
|
|||||
|
2020
Q4 | $79.6M | Buy |
|
|||||
|
2020
Q3 | $68.3M | Buy |
|
|||||
|
2020
Q2 | $77.8M | Buy |
|
|||||
|
2020
Q1 | $69.8M | Buy |
|
|||||
|
2019
Q4 | $111M | Hold |
|
|||||
|
2019
Q3 | $68M | Buy |
|
|||||
|
2019
Q2 | $100M | Buy |
|
|||||
|
2019
Q1 | $107M | Buy |
|
|||||
|
2018
Q4 | $58.6M | Buy |
|
|||||
|
2018
Q3 | $81.7M | Buy |
|
|||||
|
2018
Q2 | $71.2M | Buy |
|
|||||
|
2018
Q1 | $68.9M | Hold |
|
|||||
|
2017
Q4 | $51.4M | Buy |
|
|||||
|
2017
Q3 | $13.6M | Buy |
|
|||||
|
2017
Q2 | $1.94M | Buy |
|